New study tests opioid destruction bags to keep leftover pills out of wrong hands
NCT ID NCT05875857
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how patients use and store opioid pain pills after knee or hip replacement surgery, and whether teaching them about safe destruction helps. About 163 adults will get a special handout and a Deterra bag to destroy leftover pills. Researchers will call them 6-8 weeks later to see if they used the bag and how they stored their medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Opioid destruction education and Deterra bag
What this could lead to
If successful, this could show that simple education and destruction bags help reduce leftover opioids in homes, potentially lowering misuse.
What could go wrong
This is a small, single-center study with no control group, so results may not apply broadly. It only measures patient-reported plans, not actual destruction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States